{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (2026Q2)",
      "prediction": "MISS",
      "answer": "pred ~$2.20 vs. cons $2.23",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (2026Q2)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.12B vs. cons $1.11B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "International adjusted operating income (2026Q2)",
      "prediction": "MISS",
      "answer": "pred ~$27.5M vs. cons $28.96M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.80 midpoint vs. cons $8.73 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.0% midpoint vs. cons 3.0% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest EPS miss and International operating-income shortfall should pressure the initial reaction, but unchanged FY2026 guidance limits outright estimate cuts. The midpoint would require roughly $4.80 of second-half EPS versus current consensus near $4.70, preventing a full rebound while the discounted valuation limits additional downside.",
  "day5_confidence": "MEDIUM"
}